These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 8415555
1. Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities. Chowdhury MS, el Harith A, al Massum A, al Karim E, al Rahman A. Parasitol Res; 1993; 79(6):444-50. PubMed ID: 8415555 [Abstract] [Full Text] [Related]
2. Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production. Chowdhury MS, al Masum A, al Karim E, Semiáo-Santos S, Rahman KM, Ar-Rashid H, el Harith A. Arch Inst Pasteur Tunis; 1993; 70(3-4):333-44. PubMed ID: 7802488 [Abstract] [Full Text] [Related]
3. Visceral leishmaniasis in selected communities of Hamar and Banna-Tsamai districts in Lower Omo Valley, South West Ethiopia: Sero-epidemological and Leishmanin Skin Test Surveys. Bekele F, Belay T, Zeynudin A, Hailu A. PLoS One; 2018; 13(5):e0197430. PubMed ID: 29795589 [Abstract] [Full Text] [Related]
4. Seropositivity of Visceral leishmaniasis on people of VL endemic three districts of Nepal. Basnyat S, Banjara MR, Ghimire P, Matlashewski G, Singh A. Parasitol Int; 2021 Feb; 80():102236. PubMed ID: 33147500 [Abstract] [Full Text] [Related]
5. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India. Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, Chourasia A, Singh AK, Shankar R, Menten J, Wilson ME, Boelaert M, Sundar S. PLoS Negl Trop Dis; 2013 Feb; 7(2):e2053. PubMed ID: 23459501 [Abstract] [Full Text] [Related]
7. Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. Gidwani K, Kumar R, Rai M, Sundar S. Am J Trop Med Hyg; 2009 Mar; 80(3):345-6. PubMed ID: 19270279 [Abstract] [Full Text] [Related]
9. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain. Bangert M, Flores-Chávez MD, Llanes-Acevedo IP, Arcones C, Chicharro C, García E, Ortega S, Nieto J, Cruz I. PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006277. PubMed ID: 29494596 [Abstract] [Full Text] [Related]
11. Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis. Banu SS, Meyer W, Ahmed BN, Kim R, Lee R. Trans R Soc Trop Med Hyg; 2016 May; 110(5):286-93. PubMed ID: 27198212 [Abstract] [Full Text] [Related]
19. A sero-epidemiological study of visceral leishmaniosis in Izmir District, Turkey. Altintas N, Yolasigmaz A, Sakru N, Yazar S, Ertug S, Ozbel Y. J Egypt Soc Parasitol; 1998 Aug; 28(2):389-94. PubMed ID: 9707668 [Abstract] [Full Text] [Related]
20. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme. Hossain MS, Kumar A, Hossain AFMA, Mahshin M, Sharma A, Hossain MA, Sharma V, Haque R, Shamsuzzaman AKM, Maruf S, Ghosh P, Ahuja V, Mondal D. Infect Dis Poverty; 2018 Aug 13; 7(1):80. PubMed ID: 30099967 [Abstract] [Full Text] [Related] Page: [Next] [New Search]